• Johnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, including 428 held in a 401(k).
• Filing also reports employee stock options covering 122,556 shares, exercise prices from $151.41 to $243.45.
• Restricted share units total 5,337 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000200406-26-000177), on September 01, 2026, and is solely responsible for the information contained therein.